Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025
Bionano Genomics (Nasdaq: BNGO) will report its third quarter 2025 financial results and host a conference call and live webcast on Thursday, November 13, 2025 at 4:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bionano Genomics (Nasdaq: BNGO) will report its third quarter 2025 financial results and host a conference call and live webcast on Thursday, November 13, 2025 at 4:30 p.m. ET.
Investors can join via the live webcast at https://edge.media-server.com/mmc/p/4jh5a49o or register through the participant link; a replay will be archived on the company investor relations site for at least 30 days.
Company and investor relations contacts are provided for follow-up inquiries.
Details
News Market Reaction – BNGO
On Oct 31, the first trading day after this news, BNGO closed 0.56% above the previous close.
Data tracked by StockTitan Argus for the Oct 31 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, November 13, 2025, at 4:30 p.m. Eastern Time to report financial results for the third quarter 2025 and to highlight recent corporate progress.
Conference Call & Webcast Details
| Date: | Thursday, November 13th, 2025 |
| Time: | 4:30 p.m. ET |
| Participant Link: | Registration – Click here |
| Webcast Link: | https://edge.media-server.com/mmc/p/4jh5a49o |
Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano’s investor relations website at https://ir.bionano.com/ for at least 30 days.
CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
Kelly Gura
Gilmartin Group
+1 (212) 229-6163
IR@bionano.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.